Purified Anti-human CD11a Antibody *HI111*
HI111 is an anti-human monoclonal antibody that forms an immune complex with the CD11a antigen. CD11a (also known as Integrin alpha-L or LFA-1α chain) is a 170 - 180 kD transmembrane protein that is expressed on the surface of cells such as granulocytes and macrophages. CD11a has been associated with critical biological processes like cell-cell adhesion, especially leukocyte cell-cell adhesion. Moreover, it is a member of essential cellular pathways, for instance, the integrin-mediated signaling pathway. From a research standpoint, it is of biological interest due to its association with vital macromolecules/ligands such as CD18 and ICAM-1, 2, 3 and 4. CD11a is a fairly uncommon antibody target, with a little more than 3700 publications in the last decade. Even still, CD11a has a variety of applications in neuroscience and innate immunity research, typically serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography.
Conjugation
We provide custom conjugation services for this antibody (eg. labeling of cd11a antibody with HRP). A list of available labels can be found in the table below:
For additional information about custom conjugations, please consult our services page here.
AF | AF350, AF488, AF555, AF594, AF647, AF680, AF700, AF750 |
Proteins | HRP, Alkaline Phosphatase, Streptavidin |
Tandems | APC, APC/Cy7, APC/AF750, APC/iFluor™ 700, APC/iFluor™ 750, PE, PE/Cy5, PE/Cy7, PE/AF610, PE/AF700, PE/iFluor™ 594, PE/iFluor™ 647, PE/iFluor™ 700, PE/iFluor™ 750, PE/Texas Red®, PerCP, PerCP/Cy5.5 |
Small Molecules | Biotin |
Traditional Dyes | FITC (fluorescein), TRITC, PacBlue, PacOrange, Cy3, Cy5 |
iFluor | 350, 405, 430, 450, 488, 514, 532, 546, 555, 560, 568, 594, 610, 633, 647, 660, 670, 680, 700, 710, 750, 790, 800, 810, 820, 840, 860, A7 |
mFluor | UV375, UV460, Violet 450, Violet 500, Violet 510, Violet 540, Blue 570, Green 620, Red 700, Red 780 |
For additional information about custom conjugations, please consult our services page here.
Page updated on October 14, 2024